To advance the possibility of off-the-shelf cardiac cell therapies, scientists devise an engineered cardiac stem cell that avoids stimulating a detrimental immune attack.

A study in mice reveals that stem cell transplants, currently in clinical trials, may not actually require the cells.

Slowing to just two beats per minute, the animals’ heart rate shows how they survive plunging far below the ocean’s surface to eat.

A clinical trial is underway to see if suspended animation, in which the body is cooled to 10–15 °Celsius, could slow patients’ decline and give doctors time to operate.

Scientists show the approach can kill cells that cause hardening of heart tissue in mice.

A case study of a family demonstrates that different genetic mutations from the two parents cause severe heart disease symptoms in the children.

Patients in a study of catheter ablation who showed signs of more injury to nerve cells and glia in the heart had fewer symptoms after the treatment.

CRISPRed heart muscle cells from humans gain the ability to make a protein missing in Duchenne muscular dystrophy.

By zooming in on a developing mouse heart, scientists are studying whether defects in vasculature contribute to a thin muscle wall.